6409T4C D18S40 haplotype was also associated with schizophrenia (P ¼ 0.012), while the 6409T4C-D18S40-(P ¼ 0.274) and D18S852-D18S40 (P ¼ 0.138) were not. The C18orf1 protein is predicted to have a
SIR -The pathophysiology of severe depression may be associated with mutual immune and hypothalamic-pituitary-adrenal (HPA) system activation, 1,2 by which infection-induced immune response is triggering the HPA system, thereby changing behavior, 3 and stress hormones, in turn, the immune system. 4 In this context, we investigated infections with two independent agents (Borna disease virus (BDV) and Chlamydia pneumoniae (CP)), one of which already under debate to specifically contribute to depression. [5] [6] [7] [8] Our study provides the first clinical evidence that in depressed patients, infection with Bornavirus is associated with activation of the HPA system.
The study enrolled 48 patients with a major depressive episode (DSM-IV), giving informed consent and presenting with at least 18 points in the Hamilton Depression Scale (HAMD) after a 6-day wash-out, who were kept off psychotropic medication for 1 week (except lorazepam and zolpidem) and subsequently treated with 150 mg amitriptyline or 40 mg paroxetine for weeks 1-4. Excluded were patients with schizophrenia, bipolar or current substance-related disorders. Saliva cortisol was measured daily at 8.00, 16.00 and 22.00 h during weeks À1 to 4, and mean daily concentrations were calculated each week. Citrated blood was drawn weekly for 6 weeks. IgG, IgM and IgA antibodies to CP were analyzed twice (weeks À1 and 4) using a commercially available assay. BDV structural proteins p40 and p24 and specific circulating immune complexes (CICs), together indicating antigenemia as a result of viral replication, were determined by enzyme immune assays (EIAs) using specific monoclonal antibodies. 5, 8 BDV antigen-positive scoring requested moderate or high reactivity in the BDV-CIC and/or plasma antigen EIA. Nonreactivity in either assay was considered BDV negative. Laboratories (endocrinology, microbiology) were mutually kept blind as to their results. Analysis of variance with repeated measures (ANOVA-rm) and t-tests were used to compare HPA system activity between subgroup of patients.
A total of 16 patients were BDV antigen positive at one or more time points, while 17 did not show positive BDV antigen in any of 6-weekly blood samples. In all, 15 subjects were excluded because BDV antigen results did not allow clear stratification. BDV antigen-positive and -negative subgroups did not differ with respect to age (54712 vs 52713 years), pre-treatment, severity (HAMD: 2474 vs 2475) or subtype of depression, antidepressive treatment (seven paroxetine/nine amitriptyline vs nine paroxetine/ eight amitriptyline) or use of lorazepam during the study or HAMD score at day 28 (1579 vs 1176). A higher proportion of women (13/22) than men (3/11) was BDV antigen positive.
Using ANOVA-rm, we found increased baseline cortisol in the BDV antigen positive compared to the negative group (effect of group: F 1 BDV infection was studied with respect to its potential role in depression, suggested by mRNA/ antigen in such patients' blood and cerebrospinal fluid, virus isolates from white blood cells, 5 and antigenemia correlating with severity. 7, 8 Further, a relation, whatsoever, of depressed patients' HPA system activity to impaired immune functions, thereby promoting BDV replication, was hypothesized. 6 Our findings add evidence to this assumption, showing high pretreatment cortisol concentrations in such patients together with signs of replication of a neurotropic virus, causing CNS cytokine expression (9) and behavioral disorders in animals. 7 However, this does not provide sufficient evidence for any causal relation. Clinically, no significant difference between BDV antigen-positive and -negative patients could be detected. Our data still leave several plausible modes of interaction between the HPA system and BDV replication: hippocampal BDV infection or BDV-induced cytokine response may lead to HPA feedback dysregulation or increased HPA activity may lead to impaired immune function and BDV replication. BDV activation possibly preceding HPA system activation would be in accordance with changes of cytokine and endocrine signaling in the context of inflammation.
